CareRx Corporation (TSX:CRRX)
Canada · Delayed Price · Currency is CAD 3.220
-0.020 (-0.62%)
Aug 26, 2026, 3:59 PM EST
CareRx Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 376.8 | 370.24 | 366.71 | 370.75 | 381.73 | 262.63 | |
Revenue Growth | 2.96% | 0.96% | -1.09% | -2.88% | 45.35% | 61.92% |
Cost of Revenue | 263.65 | 259.28 | 258.65 | 266.05 | 271.79 | 187.35 |
Gross Profit | 113.14 | 110.96 | 108.06 | 104.7 | 109.93 | 75.28 |
Selling, General & Admin | 100.81 | 99.56 | 101.28 | 97.87 | 102.55 | 70.52 |
Operating Expenses | 100.81 | 99.56 | 101.28 | 97.87 | 102.55 | 70.52 |
Operating Income | 12.34 | 11.4 | 6.78 | 6.83 | 7.38 | 4.76 |
Interest Expense | -6.25 | -6.65 | -8.9 | -13.86 | -14.89 | -14.65 |
Interest & Investment Income | 0.21 | 0.16 | 0.06 | 1.26 | 0.28 | 0.06 |
Other Non Operating Income (Expenses) | -0.2 | -0.2 | -0.29 | -0.13 | 5.24 | -2.24 |
EBT Excluding Unusual Items | 6.1 | 4.72 | -2.34 | -5.91 | -1.98 | -12.08 |
Merger & Restructuring Charges | -1.19 | -1.29 | -1.49 | -1.45 | -5 | -8.06 |
Impairment of Goodwill | - | - | - | - | -22.52 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | -2.71 | - |
Asset Writedown | - | - | -0.76 | -0.71 | -1.81 | - |
Other Unusual Items | -0.06 | -0.08 | 0.13 | -1.53 | -1.87 | -3.6 |
Pretax Income | 4.85 | 3.35 | -4.47 | -9.6 | -35.9 | -23.74 |
Income Tax Expense | -22.02 | -22.77 | 0.03 | -4.19 | -1.54 | -1.01 |
Earnings From Continuing Operations | 26.87 | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 |
Net Income to Company | 26.87 | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 |
Net Income | 26.87 | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 |
Net Income to Common | 26.87 | 26.13 | -4.5 | -5.41 | -34.35 | -22.73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 63 | 63 | 60 | 57 | 48 | 35 |
Shares Outstanding (Diluted) | 65 | 64 | 60 | 57 | 48 | 35 |
Shares Change | 5.06% | 7.03% | 5.06% | 20.49% | 36.54% | 72.00% |
EPS (Basic) | 0.43 | 0.42 | -0.07 | -0.09 | -0.72 | -0.65 |
EPS (Diluted) | 0.42 | 0.41 | -0.07 | -0.09 | -0.72 | -0.65 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 24.7 | 25.23 | 32.4 | 22.65 | 12.29 | 1.92 |
Free Cash Flow Per Share | 0.38 | 0.39 | 0.54 | 0.40 | 0.26 | 0.06 |
Dividend Per Share | 0.080 | 0.040 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 30.03% | 29.97% | 29.47% | 28.24% | 28.80% | 28.66% |
Operating Margin | 3.27% | 3.08% | 1.85% | 1.84% | 1.93% | 1.81% |
Profit Margin | 7.13% | 7.06% | -1.23% | -1.46% | -9.00% | -8.65% |
Free Cash Flow Margin | 6.56% | 6.81% | 8.84% | 6.11% | 3.22% | 0.73% |
EBITDA | 24.06 | 25.54 | 22.06 | 22.89 | 21.74 | 16.96 |
EBITDA Margin | 6.39% | 6.90% | 6.02% | 6.17% | 5.69% | 6.46% |
D&A For EBITDA | 11.72 | 14.14 | 15.28 | 16.07 | 14.35 | 12.21 |
EBIT | 12.34 | 11.4 | 6.78 | 6.83 | 7.38 | 4.76 |
EBIT Margin | 3.27% | 3.08% | 1.85% | 1.84% | 1.93% | 1.81% |